PBX1 expression in uterine natural killer cells drives fetal growth.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 28 02 2019
revised: 19 11 2019
accepted: 12 02 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 1 6 2021
Statut: ppublish

Résumé

Abundant decidual natural killer (dNK) cells at the maternal-fetal interface are important during early pregnancy. However, functional subsets of dNK cells remain poorly understood. We describe a CD49a

Identifiants

pubmed: 32238574
pii: 12/537/eaax1798
doi: 10.1126/scitranslmed.aax1798
pii:
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Yonggang Zhou (Y)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.
First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui 230026, China.

Binqing Fu (B)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China. ustcwhm@ustc.edu.cn tzg@ustc.edu.cn fbq@ustc.edu.cn.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.

Xiuxiu Xu (X)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.

Jinghe Zhang (J)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.

Xianhong Tong (X)

First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui 230026, China.

Yanshi Wang (Y)

First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui 230026, China.

Zhongjun Dong (Z)

School of Medicine, Tsinghua University, Beijing 100086, China.

Xiaoren Zhang (X)

CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200025, China.

Nan Shen (N)

Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China.

Yiwen Zhai (Y)

Center for Genetic and Prenatal Diagnosis, Department of Gynecology and Obstetrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.

Xiangdong Kong (X)

Center for Genetic and Prenatal Diagnosis, Department of Gynecology and Obstetrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.

Rui Sun (R)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.

Zhigang Tian (Z)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China. ustcwhm@ustc.edu.cn tzg@ustc.edu.cn fbq@ustc.edu.cn.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.

Haiming Wei (H)

Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China. ustcwhm@ustc.edu.cn tzg@ustc.edu.cn fbq@ustc.edu.cn.
Institute of Immunology, University of Science and Technology of China, Hefei, Anhui 230027, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH